Publications by authors named "Anne M Gold"

Claim this Profile
A
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC).
Ana M Molina, Thomas E Hutson, James Larkin, Anne M Gold, Karen Wood

Cancer Chemother Pharmacolยท January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis